中醫(yī)藥干預(yù)乳腺癌復(fù)發(fā)轉(zhuǎn)移的臨床研究.pdf

1、南京中醫(yī)藥大學(xué)碩士學(xué)位論文中醫(yī)藥干預(yù)乳腺癌復(fù)發(fā)轉(zhuǎn)移的臨床研究姓名：谷雨申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：中醫(yī)內(nèi)科學(xué)指導(dǎo)教師：吳勉華20080501TheclinicalinvestigationabouttheinfluenceofChinesemedicaltherapyindelayingbreastcancer’srecidivationandmetastasisafteroperationThearticlediscussestheinf

2、luenceofChinesemedicaltherapyindelayingbreastcancersrecidivationandmetastasisafteroperationItalsoprobesthedependabilitybetweendifferentChinesemedicaltypeofsyndromeandrecidivationandmetastasisResultsoftheoreticalstudyThet

3、raditionalChinesemedicine，etiologicalfactorandpathogenesis，therapyandvariouskindsofprognosisfactollswereanalyzedinthisthesisNumbemofdomesticandovereasstudyadvancementsofbreastcancer’srecidivationandmetastasiswereexposedA

4、tfwst，itcollectseverypatients’recordsasfollows：age，clinicalstage，tumorsize，pathologictype，differentiationofChinesemedicalsymptomsandsigns，treatmentbyChinesemedicineetcThenitobserveshowdifferentiationofChinesemedicalsympt

5、omsandsigns，treatmentbyChinesemedcineaffectontheDFSResultsofclinicalstudy120CasesofII、ⅢstagingbreastcancerwhohadbeendonetheoperationwerechosenAfterstatisticsanalysis，DFSofthepatientsinvolvedintreatmentofChinesemedicineis

6、longerthanthosewhoarewithouttreatmentofChinesemedicineinII、IlIAstagingbreastcancerpatiems，astotheIIICstagingpatients，ithasn’tstatisticalsignificanceViaCOXmultiplicity，itshows：pathologictype，ER，PR，neoadjuvantchemotherapya

7、nddurationoftakeingChinesemedicinehavepredominantdependabilitywithDFSWhosetypesarestagnationofvitalenergyandbloodstasisappearancethehighestrecidivationandmetastasisrateWhilethosetypesaredeficiencyofbothvitalenergyandYinh

8、avethelongestDFSDrawaconclusion：TakingChinesemedicineafteroperationforalongtimemaybebenefitsinprolongingpatient’SDFS，andprognosisisbestintypeofdeficiencyofvitalenergyandYinwhilewontinstagnationofvitalenergyandbloodstasis